CRISPR Therapeutics

CRISPR Therapeutics

Biotechnology Research Boston, Ma, United States 385 employees
Employees
385
Contacts
2
Emails
2

CRISPR Therapeutics Overview

Headquarters
Boston, Ma, United States
Phone Number
Available in AeroLeads
Website
crisprtx.com
Industry
Biotechnology Research
Employees
385
Founded
2013
Funding
280.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About CRISPR Therapeutics

Since its inception over a decade ago, CRISPR Therapeutics has evolved from a research-stage company advancing gene editing programs into a leader that celebrated the historic approval of the first-ever CRISPR-based therapy. The Company has a diverse portfolio of product candidates across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, cardiovascular, autoimmune, and rare diseases. In 2018, CRISPR Therapeutics advanced the first-ever CRISPR/Cas9 gene-edited therapy into the clinic to investigate the treatment of sickle cell disease and transfusion-dependent beta thalassemia. Beginning in late 2023, CASGEVY® (exagamglogene autotemcel [exa-cel]) was approved in several countries to treat eligible patients with either of these conditions. The Nobel Prize-winning CRISPR technology has revolutionized biomedical research and represents a powerful, clinically validated approach with the potential to create a new class of potentially transformative medicines. To accelerate and expand its efforts, CRISPR Therapeutics has formed strategic partnerships with leading companies including Vertex Pharmaceuticals. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Boston, Massachusetts and San Francisco, California.

CRISPR Therapeutics Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage

CRISPR Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Robert Stern
View
Megan Wherry Menner Senior Vice President, Head of Human
View
Daniel Hostetter
Email
Edd Fleming Supporting Life Science Companies
Email

Employees by Management Level

Individual contributor 10 profiles
Manager 9 profiles
Director 6 profiles
Senior / Lead 6 profiles
Executive 4 profiles

Department Contact Coverage

Department Contacts Email Phone
General 5 5 2
Healthcare 5 5 2
IT 5 5 0
Operations 3 3 1
Executive 1 1 1
Finance 1 1 0

CRISPR Therapeutics Tech Stack

Engineering 5 profiles
Data / AI 2 profiles

Compare Similar Companies to CRISPR Therapeutics